切换至 "中华医学电子期刊资源库"
高级检索
中华消化病与影像杂志(电子版)

中华消化病与影像杂志(电子版) ›› 2022, Vol. 12 ›› Issue (02) : 102 -107. doi: 10.3877/cma.j.issn.2095-2015.2022.02.008

综述

超声内镜引导下穿刺诊断胰腺癌的方法研究进展
李晨帆1, 吴立桦2, 郑泽宇1, 郑月萍2, 谢韵1, 刘婕2, 吴碧芳2, 苏瑞章2, 万曼3, 田钊旭4, 胡益群5,†()   
  1. 1. 361012　福建厦门，厦门大学附属中山医院消化内科
    2. 350004　福州，福建医科大学第三临床医学院；361012　福建厦门，厦门大学附属中山医院消化内科
    3. 434000　湖北荆州，荆州市第一人民医院消化内科
    4. 518172　广东深圳，深圳市龙岗区人民医院消化内科
    5. 361012　福建厦门，厦门大学附属中山医院消化内科；350004　福州，福建医科大学第三临床医学院
  • 收稿日期:2021-06-08 出版日期:2022-04-01
  • 通信作者: 胡益群
  • 基金资助:
    厦门市医疗卫生指导性项目(3502Z20214ZD1044)

Progress of diagnostic methods of pancreatic cancer by endoscopic ultrasound-guided fine-needle aspiration

Chenfan Li1, Lihua Wu2, Zeyu Zheng1, Yueping Zheng2, Yun Xie1, Jie Liu2, Bifang Wu2, Ruizhang Su2, Man Wan3, Zhaoxu Tian4, Yiqun Hu5,†()   

  1. 1. Department of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China
    2. The Third Clinical Medical College, Fujian Medical University, Fuzhou 350004, China; Department of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China
    3. Department of Gastroenterology, The Jingzhou First People's Hospital, Jingzhou 434000, China
    4. Department of Gastroenterology, Shenzhen Longgang District People's Hospital, Shenzhen 518172, China
    5. Department of Gastroenterology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China; The Third Clinical Medical College, Fujian Medical University, Fuzhou 350004, China
  • Received:2021-06-08 Published:2022-04-01
  • Corresponding author: Yiqun Hu
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

李晨帆, 吴立桦, 郑泽宇, 郑月萍, 谢韵, 刘婕, 吴碧芳, 苏瑞章, 万曼, 田钊旭, 胡益群. 超声内镜引导下穿刺诊断胰腺癌的方法研究进展[J/OL]. 中华消化病与影像杂志(电子版), 2022, 12(02): 102-107.

Chenfan Li, Lihua Wu, Zeyu Zheng, Yueping Zheng, Yun Xie, Jie Liu, Bifang Wu, Ruizhang Su, Man Wan, Zhaoxu Tian, Yiqun Hu. Progress of diagnostic methods of pancreatic cancer by endoscopic ultrasound-guided fine-needle aspiration[J/OL]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2022, 12(02): 102-107.

超声内镜引导下细针穿刺活检（EUS-FNA）是一种较为安全、并发症少的诊断方法，是获取少量胰腺组织的简便方法。对穿刺获得的组织、囊液、洗脱液等标本进行进一步检查是辨别胰腺病变良恶性的有效措施。如何选择最佳的诊断方法，从而提高EUS-FNA的诊断效能是临床面临的重要课题。本文总结了目前临床常见的EUS-FNA辅助诊断方法，如细胞学、肿瘤标志物、基因检测等，并比较了不同方法的优缺点。液基细胞学检查不如传统涂片方法的细胞异型性明显，但减少了样品背景的污染。在肿瘤标志物及基因检测方面，除了p53、KRAS、糖类抗原等标志物，SMAD4基因、IMP3、S100P蛋白等也是经研究证实有诊断价值的生物标志物。新技术如高通量测序有成为临床检测方法的潜能，在有足够人手的医院，也推荐实施快速现场评价技术。

关键词: 超声内镜引导下穿刺, 细胞学, 基因, 肿瘤标志物, 诊断

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a relatively safe diagnostic method with fewer complications, and a simple method to obtain a small amount of pancreatic tissue. Further examination of tissue, cystic fluid and washing fluid obtained by aspiration is an effective way to distinguish benign and malignant pancreatic lesions. How to select the best diagnostic method to improve the diagnostic efficiency of EUS-FNA is an important topic in clinical research. This review discusses common diagnostic methods of EUS-FNA, such as cytology, tumor markers, gene testing, and the advantages and disadvantages of different methods are compared. Liquid-based cytology lacks uniformity compared to the conventional smear method but reduces contamination of the background. In terms of the detection of tumor markers and genes, in addition to p53, KRAS, carbohydrate antigen, SMAD4 gene, IMP3, S100P protein are also worthy biomarkers confirmed by studies. New technology such as high-throughput sequencing has the potential to be used in clinical practice, and rapid on-site evaluation is recommended in fully staffed hospitals.

Key words: Endoscopic ultrasound-guided fine-needle aspiration, Cytology, Gene, Tumor markers, Diagnosis
1
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
2
Ilic M, Ilic I. Epidemiology of pancreatic cancer [J]. World J Gastroenterol, 2016, 22(44): 9694-9705.
3
Berry W, Lundy J, Croagh D, et al. Reviewing the Utility of EUS FNA to Advance Precision Medicine in Pancreatic Cancer [J]. Cancers (Basel), 2018, 10(2): 35.
4
李诗钰,王凯旋,金震东.超声内镜在胰腺癌诊断中的应用与研究进展[J].临床荟萃, 2019, 34(9): 773-776.
5
Saqib M, Maruf M, Bashir S, et al. EUS-FNA, ancillary studies and their clinical utility in patients with mediastinal, pancreatic, and other abdominal lesions [J]. Diagn Cytopathol, 2020, 48(11): 1058-1066.
6
蔡国平.病理科医师看快速现场评价[J].中华结核和呼吸杂志, 2018, 41(6): 504-506.
7
管枫,袁静萍,何惠华.超声内镜引导下细针穿刺传统涂片细胞学、液基细胞学及组织学结果对比及不一致原因分析[J].临床与实验病理学杂志, 2019, 35(11): 1360-1363.
8
Zhou W, Gao L, Wang SM, et al. Comparison of smear cytology and liquid-based cytology in EUS-guided FNA of pancreatic lesions: experience from a large tertiary center [J]. Gastrointest Endosc, 2020, 91(4): 932-942.
9
Chun JW, Lee K, Lee SH, et al. Comparison of liquid-based cytology with conventional smear cytology for EUS-guided FNA of solid pancreatic masses: a prospective randomized noninferiority study [J]. Gastrointest Endosc, 2020, 91(4): 837-846.e1.
10
Hashimoto S, Taguchi H, Higashi M, et al. Diagnostic efficacy of liquid-based cytology for solid pancreatic lesion samples obtained with endoscopic ultrasound-guided fine-needle aspiration: Propensity score-matched analysis [J]. Dig Endosc, 2017, 29(5): 608-616.
11
盛显仓,汪洋,郑佳,等.液基细胞学和传统细胞学在消化道肿瘤诊断中的价值[J].中华消化杂志, 2013, 33(9): 628-629.
12
费鸣剑,吴斌,钟征翔.细胞学涂片及其联合细胞块免疫组化在超声内镜下细针穿刺活检术中的应用价值[J].中国内镜杂志, 2019, 25(9): 65-69.
13
覃山羽,姜海行,李萍,等.细胞块结合免疫组化在内镜超声引导下穿刺诊断胰腺实性占位中的应用价值[J].中华消化内镜杂志, 2014, 31(6): 312-316.
14
Sweeney J, Rao R, Margolskee E, et al. Immunohistochemical staining for S100P, SMAD4, and IMP3 on cell block preparations is sensitive and highly specific for pancreatic ductal adenocarcinoma [J]. J Am Soc Cytopathol, 2018, 7(6): 318-323.
15
Matsuda Y, Esaka S, Suzuki A, et al. Abnormal immunolabelling of SMAD4 in cell block specimens to distinguish malignant and benign pancreatic cells [J]. Cytopathology, 2019, 30(2): 201-208.
16
Wong N, Gwiti P, Murigu T, et al. Cell block processing is optimal for assessing endoscopic ultrasound fine needle aspiration specimens of pancreatic mucinous cysts [J]. J Clin Pathol, 2020, 73(2): 102-106.
17
Sung S, Del Portillo A, Gonda TA, et al. Update on risk stratification in the Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology categories: 3-Year, prospective, single-institution experience [J]. Cancer Cytopathol, 2020, 128(1): 29-35.
18
叶乔,陈柯,刘倩倩,等.超声内镜引导下细针穿刺结合巴氏细胞学分级诊断胰腺实性病变的价值[J].中华消化杂志, 2017, 37(12): 823-827.
19
Saieg M, Pitman MB. Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology [J]. Diagn Cytopathol, 2020, 48(5): 494-498.
20
Hoda RS, Finer EB, Arpin RN 3rd, et al. Risk of malignancy in the categories of the Papanicolaou Society of Cytopathology system for reporting pancreaticobiliary cytology [J]. J Am Soc Cytopathol, 2019, 8(3): 120-127.
21
Iwatate Y, Hoshino I, Yokota H, et al. Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer [J]. Br J Cancer, 2020, 123(8): 1253-1261.
22
Cicenas J, Kvederaviciute K, Meskinyte I, et al. KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer [J]. Cancers (Basel), 2017, 9(5): 42.
23
Moris D, Damaskos C, Spartalis E, et al. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas [J]. Anticancer Res, 2017, 37(5): 2185-2194.
24
Martínez de Juan F, Reolid Escribano M, Martínez Lapiedra C, et al. Pancreatic adenosquamous carcinoma and intraductal papillary mucinous neoplasm in a CDKN2A germline mutation carrier [J]. World J Gastrointest Oncol, 2017, 9(9): 390-396.
25
Lohse I, Borgida A, Cao P, et al. BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts [J]. Br J Cancer, 2015, 113(3): 425-432.
26
Shugang X, Hongfa Y, Jianpeng L, et al. Prognostic Value of SMAD4 in Pancreatic Cancer: A Meta-Analysis [J]. Transl Oncol, 2016, 9(1): 1-7.
27
Wang JD, Jin K, Chen XY, et al. Clinicopathological significance of SMAD4 loss in pancreatic ductal adenocarcinomas: a systematic review and meta-analysis [J]. Oncotarget, 2017, 8(10): 16704-16711.
28
孙瑞,蔡迎彬,李丹萍,等.超声内镜引导下细针穿刺活检联合基因检测对胰腺癌的诊断价值[J].现代生物医学进展, 2016, 16(30): 5921-5922, 5842.
29
Li T, Zheng Y, Sun H, et al. K-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis [J]. Med Oncol, 2016, 33(7): 61.
30
王晓光,杨晓丹,费鸣剑,等.内镜超声细针穿刺物K-ras基因突变检测对胰腺癌的诊断价值[J].中华胰腺病杂志, 2017, 17(5): 307-310.
31
Trisolini E, Armellini E, Paganotti A, et al. KRAS mutation testing on all non-malignant diagnosis of pancreatic endoscopic ultrasound-guided fine-needle aspiration biopsies improves diagnostic accuracy [J]. Pathology, 2017, 49(4): 379-386.
32
Park JK, Lee YJ, Lee JK, et al. KRAS mutation analysis of washing fluid from endoscopic ultrasound-guided fine needle aspiration improves cytologic diagnosis of pancreatic ductal adenocarcinoma [J]. Oncotarget, 2017, 8(2): 3519-3527.
33
Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors [J]. Science, 2011, 331(6021): 1199-1203.
34
Kadayifci A, Atar M, Wang JL, et al. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms [J]. Dig Endosc, 2017, 29(1): 111-117.
35
Springer S, Wang Y, Dal Molin M, et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts [J]. Gastroenterology, 2015, 149(6): 1501-1510.
36
Faias S, Duarte M, Albuquerque C, et al. Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA [J]. Dig Dis Sci, 2018, 63(9): 2351-2361.
37
Zhang Y, Yang J, Li H, et al. Tumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis [J]. Int J Clin Exp Med, 2015, 8(7): 11683-11691.
38
Wang Z, Tian YP. Clinical value of serum tumor markers CA19-9, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma [J]. Mol Clin Oncol, 2014, 2(2): 265-268.
39
Boeck S, Wittwer C, Heinemann V, et al. Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer [J]. Br J Cancer, 2013, 108(8): 1684-1694.
40
Zeng P, Li H, Chen Y, et al. Serum CA199 levels are significantly increased in patients suffering from liver, lung, and other diseases [J]. Prog Mol Biol Transl Sci, 2019, 162: 253-264.
41
Okasha H, E Behiry M, Ramadan N, et al. Endoscopic ultrasound-guided fine needle aspiration in diagnosis of cystic pancreatic lesions [J]. Arab J Gastroenterol, 2019, 20(2): 86-90.
42
Senoo J, Mikata R, Kishimoto T, et al. Immunohistochemical analysis of IMP3 and p53 expression in endoscopic ultrasound-guided fine needle aspiration and resected specimens of pancreatic diseases [J]. Pancreatology, 2018, 18(2): 176-183.
43
Tadic M, Stoos-Veic T, Kujundzic M, et al. Insulin-like growth factor 2 binding protein 3 expression on endoscopic ultrasound guided fine needle aspiration specimens in pancreatic ductal adenocarcinoma [J]. Eur J Gastroenterol Hepatol, 2020, 32(4): 496-500.
44
Ohuchida K, Mizumoto K, Egami T, et al. S100P is an early developmental marker of pancreatic carcinogenesis [J]. Clin Cancer Res, 2006, 12(18): 5411-5416.
45
Hu H, Zhang Q, Huang C, et al. Diagnostic value of S100P for pancreatic cancer: a meta-analysis [J]. Tumour Biol, 2014, 35(10): 9479-9485.
46
Camara R, Ogbeni D, Gerstmann L, et al. Discovery of novel small molecule inhibitors of S100P with in vitro anti-metastatic effects on pancreatic cancer cells [J]. Eur J Med Chem, 2020, 203: 112621.
47
Chiba M, Imazu H, Kato M, et al. Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma [J]. Oncol Rep, 2017, 37(4): 1943-1952.
48
Jin H, Liu P, Wu Y, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer [J]. Cancer Sci, 2018, 109(9): 2946-2956.
49
Xu C, Wallace MB, Yang J, et al. ZIP4 is a novel diagnostic and prognostic marker in human pancreatic cancer: a systemic comparison between EUS-FNA and surgical specimens [J]. Curr Mol Med, 2014, 14(3): 309-315.
50
向青,万涛,胡前方,等.快速现场细胞学评价在EBUS-TBNA取样诊断肺癌中的价值[J].中国肺癌杂志, 2018, 21(11): 833-840.
51
覃善君,张朝顺,杨新魁,等.快速现场评价技术在消化道占位性病变诊断中的价值[J].新医学, 2020, 51(4): 294-298.
52
Ishizawa T, Makino N, Matsuda A, et al. Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective study [J]. PLoS One, 2020, 15(1): e0228565.
53
Lisotti A, Frazzoni L, Fuccio L, et al. Repeat EUS-FNA of pancreatic masses after nondiagnostic or inconclusive results: systematic review and meta-analysis [J]. Gastrointest Endosc, 2020, 91(6): 1234.e4-1241.e4.
54
Wani S, Mullady D, Early DS, et al. The clinical impact of immediate on-site cytopathology evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: a prospective multicenter randomized controlled trial [J]. Am J Gastroenterol, 2015, 110(10): 1429-1439.
55
Estrada P, Benson M, Gopal D, et al. Cytology with rapid on-site examination (ROSE) does not improve diagnostic yield of EUS-FNA of pancreatic cystic lesions [J]. Diagn Cytopathol, 2019, 47(11): 1184-1189.
56
Yang F, Liu E, Sun S. Rapid on-site evaluation (ROSE) with EUS-FNA: The ROSE looks beautiful [J]. Endosc Ultrasound, 2019, 8(5): 283-287.
57
Kameta E, Sugimori K, Kaneko T, et al. Diagnosis of pancreatic lesions collected by endoscopic ultrasound-guided fine-needle aspiration using next-generation sequencing [J]. Oncol Lett, 2016, 12(5): 3875-3881.
58
Imaoka H, Sasaki M, Hashimoto Y, et al. New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer [J]. J Clin Med, 2019, 8(8): 1173.
59
Carrara S, Soldà G, Di Leo M, et al. Side-by-side comparison of next-generation sequencing, cytology, and histology in diagnosing locally advanced pancreatic adenocarcinoma [J]. Gastrointest Endosc, 2021, 93(3): 597-604.e5.
60
Singhi AD, McGrath K, Brand RE, et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia [J]. Gut, 2018, 67(12): 2131-2141.
61
Rodriguez SA, Impey SD, Pelz C, et al. RNA sequencing distinguishes benign from malignant pancreatic lesions sampled by EUS-guided FNA [J]. Gastrointest Endosc, 2016, 84(2): 252-258.
62
费鸣剑,吴斌,钟征翔.细胞学涂片及其联合细胞块免疫组化在超声内镜下细针穿刺活检术中的应用价值[J].中国内镜杂志, 2019, 25(9): 65-69.
63
Itonaga M, Murata SI, Hatamaru K, et al. Diagnostic efficacy of smear plus liquid-based cytology for EUS-FNA of solid pancreatic lesions: A propensity-matched study [J]. Medicine (Baltimore), 2019, 98(19): e15575.
64
高莉,张明华,贺相洁,等.内镜超声引导下胰腺占位性病变细针穿刺液基细胞学诊断[J].中华病理学杂志, 2016, 45(1): 43-46.
65
Archibugi L, Ruta V, Panzeri V, et al. RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features [J]. Cells, 2020, 9(12): 2561.
66
Furuhata A, Minamiguchi S, Shirahase H, et al. Immunohistochemical Antibody Panel for the Differential Diagnosis of Pancreatic Ductal Carcinoma From Gastrointestinal Contamination and Benign Pancreatic Duct Epithelium in Endoscopic Ultrasound-Guided Fine-Needle Aspiration [J]. Pancreas, 2017, 46(4): 531-538.
67
Kim H, Kang KN, Shin YS, et al. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma[J]. Cancers (Basel), 2020,12(6):1443.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(11): 1089-1091.
[2] 周容, 张亚萍, 廖宇, 程晓萍, 管玉龙, 潘广玉, 闫杰, 王贤芝, 苟中山, 潘登科, 李巅远. 超声在基因编辑猪-猴异种并联式心脏移植术中的应用价值[J/OL]. 中华医学超声杂志（电子版）, 2024, 21(06): 617-623.
[3] 唐金侨, 叶宇佳, 王港, 赵彬, 马艳宁. 医学影像学检查方法在颞下颌关节紊乱病中临床应用研究进展[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 406-411.
[4] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[5] 刘文竹, 唐窈, 刘付臣. 诱导多潜能干细胞在神经肌肉疾病研究中的应用进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 367-373.
[6] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[7] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[8] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[9] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[10] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号

AI
小
编
AI小编
你好！我是《中华医学电子期刊资源库》AI小编，有什么可以帮您的吗？